Urinary Leukotriene E4 to Determine Aspirin Intolerance in Asthma: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Urinary Leukotriene E4 to Determine Aspirin Intolerance in Asthma: A Systematic Review and Meta-Analysis

Published:2017-07 Issue:4 Volume:5 Page:990-997.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Hagan John B.,Laidlaw Tanya M.,Divekar Rohit,O'Brien Erin K.,Kita Hirohito,Volcheck Gerald W.,Hagan Christina R.,Lal Devyani,Teaford Harry G.,Erwin Patricia J.,Zhang Nan,Rank Matthew A.

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference37 articles.

1. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report;Masoli;Allergy,2004

2. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature;Rajan;J Allergy Clin Immunol,2015

3. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program;Moore;J Allergy Clin Immunol,2007

4. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma;Eur Respir J,2003

5. Recovery of leukotriene E4 from the urine of patients with airway obstruction;Drazen;Am Rev Respir Dis,1992

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin hypersensitivity diagnostic index (AHDI): In vitro test for diagnosing of N‐ERD based on urinary 15‐oxo‐ETE and LTE₄ excretion;Allergy;2024-08-23

2. Staphylococcus aureus, Superantigens, and Nasal Polyps;Nasal Polyposis and its Management;2024

3. Management of Aspirin-Exacerbated Respiratory Disease;Otolaryngologic Clinics of North America;2023-10

4. Association of eosinophil‐derived neurotoxin levels with asthma control status in patients with aspirin‐exacerbated respiratory disease;Clinical and Translational Allergy;2023-03

5. Aspirin-Exacerbated Respiratory Disease and the Unified Airway;Otolaryngologic Clinics of North America;2023-02